
Please try another search
Hey everybody Dave Bartosiak filling in for fellow Marquette alum Jimmy “The Count” Giaquinto. He’ll be back with you tomorrow after taking a much-deserved day off.
The November episode of the Zacks Ultimate Strategy Session is now available for viewing! Tune in to this "must-see" event when Sheraz Mian, David Bartosiak, Tracey Ryniec, Brian Bolan and Kevin Cook discussed the investment landscape from most every angle. Don't miss your chance to hear:
• Sheraz and Kevin Agree to Disagree on why Valuations don't matter like they used to
• Sheraz and Tracey answer your questions in Zacks Mailbag
• Sheraz and Kevin choose one portfolio to give feedback for improvement
• And much more
Simply log on to Zacks.com and view the November episode here. And please let us know what you think of the new format. Email all feedback to mailbag@zacks.com.
Dare I say a “Must-read” entry in Counterstrike today as Jeremy Mullin dropped some knowledge for all of us. He’s got the cautionary tale of the Priceline earnings reaction as well as some Fib targets on crude.
“Instead of my normal market commentary I wanted to discuss an earnings move that was pretty serious. Priceline had one of the biggest earnings blowups you’ll ever see point wise. The stock was down over $250 points, or 13.5%, after a disappointing guidance. The move put the stock below the 50-day and the 200-day and has investors asking if the bull market is over for Priceline.”
Oil was a common theme in commentary today with the good Dr. John Blank chiming in on Saudi Arabia in his Large Cap Trader portfolio that’s been absolutely crushing it since inception.
“Early gains had come despite Saudi Arabia stepping up its war of words against archrival Iran. The country, whose weekend crackdown on dozens of prices, ministers and tycoons drove up demand for haven assets on Monday, has accused Iran of “direct military aggression” by supplying missiles to Yemeni rebels, according to the state news agency.”
Today's Portfolio Highlights:
The Short List took a few scalps, ringing up profits on Ctrip.com (CTRP, 8.67%) and Oneok (OKE, 1.79%)
Brian Bolan cut bait and took a win on Tactile Systems (TCMD, 8.27%) in Home Run Investor
Kevin cook added Alexion Pharma (ALXN) to Healthcare Innovators
Some handsome devil added Paycom (PAYC) in Momentum Trader and Meritor (MTOR) in Surprise Trader.
That’s all I got for you here with Zacks Ultimate, Jim will be back with you tomorrow.
Have a great night,
Dave
Recommendations from Zacks' Private Portfolios:
Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>
Zacks Investment Research
Through many years of frustration among gold bugs due to the failure of gold stock prices to leverage the gold prices in a positive way, there were very clear reasons for that...
I know there is the smell of fear in the air when I see my readership double as we reach a point where weekly chart factors come into play. Up until last week, markets have...
Professional traders get paid because of one skill and one skill only: the ability to foresee what the world (or the economy, at least) might look like in six to nine months....
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.